Xgeva

Amgen sues Samsung biotech unit over bone drug copies
Reuters
Tue, 08/13/24 - 11:08 pm
Amgen
Samsung
biologics
biosimilars
legal
Prolia
Xgeva
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Sandoz
biosimilars
FDA
Amgen
denosumab
Prolia
Jubbonti
Xgeva
Wyost
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Wed, 05/3/23 - 10:41 pm
Amgen
Sandoz
legal
Prolia
Xgeva
patents
denosumab
Amgen's denosumab shows promise in small, NIH-funded rare bone disease study
Endpoints
Wed, 04/5/23 - 07:15 pm
Amgen
Prolia
Xgeva
denosumab
clinical trials
NIH
biosimilars
monoclonal antibodies
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Tue, 02/7/23 - 12:22 pm
Sandoz
Novartis
biosimilars
osteoporosis
Prolia
Xgeva
FDA
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Could Amgen's Xgeva boost immunotherapy in breast cancer?
Fierce Biotech
Mon, 12/14/20 - 10:37 am
Amgen
Xgeva
breast cancer
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Tue, 07/23/19 - 10:03 am
Novartis
Sandoz
biosimilars
clinical trials
denosumab
osteoporosis
Prolia
Xgeva
Amgen focuses on migraine launch as growth remains slow
Biopharma Dive
Wed, 04/25/18 - 10:54 pm
Amgen
earnings
Repatha
Kyprolis
Prolia
Xgeva
FDA expands use of Amgen's blockbuster drug
Yahoo/Reuters
Fri, 01/5/18 - 05:42 pm
FDA
Amgen
Xgeva
Multiple Myeloma
Amgen Files Marketing Applications to Expand Xgeva's Use to US and EU MM Patients
Yahoo/GuruFocus
Mon, 04/10/17 - 10:02 am
Amgen
Xgeva
Multiple Myeloma
Europe
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Tue, 09/20/16 - 09:51 am
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Market Realist
Sat, 07/30/16 - 09:53 pm
Amgen
Prolia
Xgeva
osteoporosis
Amgen reacquires rights to three drugs from Glaxo in 48 countries
Yahoo/Reuters
Mon, 12/14/15 - 10:42 pm
Amgen
GSK
Prolia
Vectibix
Xgeva
Amgen's bone drug Xgeva gets new approval
Yahoo/AP
Mon, 12/8/14 - 11:49 am
Amgen
Xgeva
hypercalcemia of malignancy
Xgeva and Prolia: Setting the Pace for Amgen, Inc.
Motley Fool
Tue, 02/4/14 - 07:48 am
Xgeva
Prolia
Amgen
FDA approves new use for Amgen drug Xgeva, for rare type of bone tumors seen in young adults
Yahoo/AP
Fri, 06/14/13 - 08:10 am
Xgeva
FDA
Amgen
Anemic Growth? Not From These Drugs.
Motley Fool
Sat, 04/28/12 - 12:19 pm
Amgen
Affymax
Takeda
Epogen
Aranesp
Pfizer
Abbott Laboratories
JNJ
Novartis
Zometa
Xgeva
Prolia
FDA rejects Amgen's application for Xgeva
Reuters
Fri, 04/27/12 - 10:31 am
FDA
Amgen
prostate cancer
Xgeva
A Picture is Worth a Thousand Words: The Difference Between "Yes" and "No" During an FDA Advisory Committee
Elsevier Business
Fri, 03/9/12 - 10:49 am
FDA
advisory panels
Xgeva
Amgen
Vivus
Qnexa

Pages